Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › OMPA and ASP14 in vaccine compositions and as diagnostic targets

OMPA and ASP14 in vaccine compositions and as diagnostic targets

US Patent 9248174 · Granted Feb 2, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Chimeric vaccine antigens for anaplasmosis2025
AipA, OmpA, and Asp14 in vaccine compositions and diagnostic targets for Anaplas2022
Chimeric vaccine antigens for anaplasmosis2022
AipA, OmpA, and Asp14 in vaccine compositions and diagnostic targets for Anaplas2020
OmpA and Asp14 in vaccine compositions and as diagnostic targets2020
OmpA in vaccine compositions and as diagnostic targets2019
OmpA and ASP14 in vaccine compositions and as diagnostic targets2019
AIPA, OMPA, and ASP14 in vaccine compositions and diagnostic targets for anaplas2018
OmpA and Asp14 in vaccine compositions and as diagnostic targets2018
OmpA in vaccine compositions and as diagnostic targets2018